Ajinath Kale

May 23, 2023 | pubs.rsc.org | Science Pilani |Pilani Campus |Vishwadeep Shelke |Ajinath Kale

Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury† Vishwadeep Shelke, a   Ajinath Kale,a   Neha Dagar,a   Tahib Habshia  and  Anil Bhanudas Gaikwad *a   Abstract Toll-like receptor-4 (TLR4) and sodium-glucose co-transporter 2 (SGLT2) signaling is involved in the pathogenesis of diabetes-associated kidney diseases.